Advertisement
Advertisement
LKFT
Lakefront Biotherapeutics - ADR
30.39
USDSponsored
+0.79
+2.67%
Jul 02, 15:59 UTC -4
Closed
After-Market
30.54
+0.15
+0.49%
LKFT Earnings Reports
Positive Surprise Ratio
LKFT beat 2 of 2 last estimates.
100%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$76.33M
/-$0.43
Implied change from Q1 26 (Revenue/ EPS)
+1077.73%
/-295.45%
Implied change from Q2 25 (Revenue/ EPS)
--
/-73.13%
Lakefront Biotherapeutics - ADR earnings per share and revenue
On May 06, 2026, LKFT reported earnings of 0.22 USD per share (EPS) for Q1 26, beating the estimate of -0.51 USD, resulting in a 142.71% surprise. Revenue reached 6.48 million, compared to an expected 71.23 million, with a -90.90% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.43 USD, with revenue projected to reach 76.33 million USD, implying an decrease of -295.45% EPS, and increase of 1077.73% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Fervo Energy Company Class A common stock
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$0.07
Actual
-$3.72
Surprise
-5169.12%
Cerebras Systems Inc. Class A Common Stock
Report Date
Jun 23, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.04
Surprise
+75.67%
Sunbelt Rentals Holdings, Inc.
Report Date
Jun 23, 2026 For Q4 26
Estimate
$0.75
Actual
$0.74
Surprise
-2.54%
HawkEye 360, Inc.
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.44
Surprise
-684.31%
Suncrete, Inc. Class A Common Stock
Report Date
Jun 24, 2026 For Q1 26
Estimate
$0.04
Actual
-$0.06
Surprise
-247.06%
Virtuix Holdings Inc. Class A Common Stock
Report Date
Jun 25, 2026 For Q4 26
Estimate
-$0.37
Actual
-$0.39
Surprise
-4.28%
FAQ
What were Lakefront Biotherapeutics - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Lakefront Biotherapeutics - ADR reported EPS of $0.22, beating estimates by 142.71%, and revenue of $6.48M, -90.9% below expectations.
How did the market react to Lakefront Biotherapeutics - ADR's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Lakefront Biotherapeutics - ADR expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Lakefront Biotherapeutics - ADR's next earnings report?
Based on --
analysts, Lakefront Biotherapeutics - ADR is expected to report EPS of -$0.43 and revenue of $76.33M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement